BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsai CY, Shen CY, Liao HT, Li KJ, Lee HT, Lu CS, Wu CH, Kuo YM, Hsieh SC, Yu CL. Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus. Int J Mol Sci 2019;20:E3878. [PMID: 31395799 DOI: 10.3390/ijms20163878] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Perdaens O, van Pesch V. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. Front Neurol 2022;12:811518. [DOI: 10.3389/fneur.2021.811518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tsai CY, Hsieh SC, Lu CS, Wu TH, Liao HT, Wu CH, Li KJ, Kuo YM, Lee HT, Shen CY, Yu CL. Cross-Talk between Mitochondrial Dysfunction-Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE. Int J Mol Sci 2019;20:E5183. [PMID: 31635056 DOI: 10.3390/ijms20205183] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Guimarães GR, Almeida PP, de Oliveira Santos L, Rodrigues LP, de Carvalho JL, Boroni M. Hallmarks of Aging in Macrophages: Consequences to Skin Inflammaging. Cells 2021;10:1323. [PMID: 34073434 DOI: 10.3390/cells10061323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lu Y, Jiang H, Li B, Cao L, Shen Q, Yi W, Ju Z, Chen L, Han F, Appelgren D, Segelmark M, de Buhr N, von Köckritz-Blickwede M, Chen J. Telomere dysfunction promotes small vessel vasculitis via the LL37-NETs-dependent mechanism. Ann Transl Med 2020;8:357. [PMID: 32355801 DOI: 10.21037/atm.2020.02.130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fülöp T, Munawara U, Larbi A, Desroches M, Rodrigues S, Catanzaro M, Guidolin A, Khalil A, Bernier F, Barron AE, Hirokawa K, Beauregard PB, Dumoulin D, Bellenger JP, Witkowski JM, Frost E. Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease. CNS Drugs 2020;34:673-95. [PMID: 32458360 DOI: 10.1007/s40263-020-00737-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
6 Tsai CY, Shen CY, Liu CW, Hsieh SC, Liao HT, Li KJ, Lu CS, Lee HT, Lin CS, Wu CH, Kuo YM, Yu CL. Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage. Biomolecules 2020;10:E1641. [PMID: 33291347 DOI: 10.3390/biom10121641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Li X, Zong L, Zhu Y, Li Y, Zhou Y, Zhou H. Penicillium janthinellum Pneumonia in an SLE Patient: A Case Study. Infect Drug Resist 2020;13:2745-9. [PMID: 32821135 DOI: 10.2147/IDR.S255968] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ding X, Xiang W, He X. IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus. Front Immunol 2020;11:581385. [PMID: 33262760 DOI: 10.3389/fimmu.2020.581385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Santos-Moreno P, Burgos-Angulo G, Martinez-Ceballos MA, Pizano A, Echeverri D, Bautista-Niño PK, Roks AJM, Rojas-Villarraga A. Inflammaging as a link between autoimmunity and cardiovascular disease: the case of rheumatoid arthritis. RMD Open 2021;7:e001470. [PMID: 33468563 DOI: 10.1136/rmdopen-2020-001470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang B, Gems D. Gross ways to live long: Parasitic worms as an anti-inflammaging therapy? Elife 2021;10:e65180. [PMID: 33526169 DOI: 10.7554/eLife.65180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Katz-Agranov N, Zandman-Goddard G. The microbiome links between aging and lupus. Autoimmun Rev 2021;20:102765. [PMID: 33476814 DOI: 10.1016/j.autrev.2021.102765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Moschetti L, Piantoni S, Vizzardi E, Sciatti E, Riccardi M, Franceschini F, Cavazzana I. Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases. Front Med 2022;9:849086. [DOI: 10.3389/fmed.2022.849086] [Reference Citation Analysis]
13 Behrouzi B, Araujo Campoverde MV, Liang K, Talbot HK, Bogoch II, McGeer A, Fröbert O, Loeb M, Vardeny O, Solomon SD, Udell JA. Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:1777-94. [PMID: 33032740 DOI: 10.1016/j.jacc.2020.08.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
14 Kälble F, Wu L, Lorenz HM, Zeier M, Schaier M, Steinborn A. Impaired Differentiation of Highly Proliferative ICOS+-Tregs Is Involved in the Transition from Low to High Disease Activity in Systemic Lupus Erythematosus (SLE) Patients. Int J Mol Sci 2021;22:9501. [PMID: 34502409 DOI: 10.3390/ijms22179501] [Reference Citation Analysis]
15 Bolton C. An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS). Immun Ageing 2021;18:18. [PMID: 33853634 DOI: 10.1186/s12979-021-00225-0] [Reference Citation Analysis]
16 Eschborn M, Pawlitzki M, Wirth T, Nelke C, Pfeuffer S, Schulte-Mecklenbeck A, Lohmann L, Rolfes L, Pape K, Eveslage M, Bittner S, Gross CC, Ruck T, Wiendl H, Meuth SG, Klotz L. Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm 2021;8:e1094. [PMID: 34667129 DOI: 10.1212/NXI.0000000000001094] [Reference Citation Analysis]